| Truncating mutations in RBM12 are associated with psychosis S Steinberg, S Gudmundsdottir, G Sveinbjornsson, J Suvisaari, T Paunio, ... Nature genetics 49 (8), 1251-1254, 2017 | 76 | 2017 |
| Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland O Ingimarsson, JH MacCabe, M Haraldsson, H Jónsdóttir, E Sigurdsson BMC psychiatry 16, 1-8, 2016 | 47 | 2016 |
| Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland O Ingimarsson, JH MacCabe, M Haraldsson, H Jónsdóttir, E Sigurdsson Nordic journal of psychiatry 71 (7), 496-502, 2017 | 25 | 2017 |
| Clozapine treatment and discontinuation in Iceland: a national longitudinal study using electronic patient records O Ingimarsson, JH MacCabe, M Haraldsson, H Jónsdóttir, E Sigurdsson Nordic journal of psychiatry 70 (6), 450-455, 2016 | 23 | 2016 |
| Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland O Ingimarsson, JH MacCabe, E Sigurdsson Nordic journal of psychiatry 72 (7), 497-500, 2018 | 19 | 2018 |
| HLA-DQB1 6672G> C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry B Konte, JTR Walters, D Rujescu, SE Legge, AF Pardiñas, D Cohen, ... Translational psychiatry 11 (1), 214, 2021 | 12 | 2021 |
| The Preadmission Nursing Home Assessment (PNHA) in Iceland in 1992-2001-Relationship to survival and admission to a long term care facility. O Ingimarsson, T Aspelund, PV Jónsson Laeknabladid 90 (2), 121-129, 2004 | 12* | 2004 |
| Birtingarmynd heilabilunar í vistunarmati aldraðra fyrir hjúkrunarrými 1992-2001 O Ingimarsson, T Aspelund, PV Jónsson | 3 | 2004 |
| Digital mental health: Co-designing a digital platform to support work in psychiatric healthcare. SG Sigurðardóttir, M Óskarsdóttir, O Ingimarsson, AS Islind STPIS, 41-51, 2022 | 1 | 2022 |
| REPLICATION OF TWO INDEPENDENT LOCI IN HLA-DQB1 AND HLA-B CONTRIBUTING TO THE RISK OF CLOZAPINE-INDUCED AGRANULOCYTOSIS B Konte, I Giegling, S Legge, D Cohen, M Pirmohamed, J Tiihonen, ... European Neuropsychopharmacology 29, S939, 2019 | 1 | 2019 |
| Geðrof í kjölfar ADHD-lyfjameðferðar: Sjúkratilfelli RK Gudbrandsdottir, E Sigurðsson, O Ingimarsson | | 2023 |
| A novel approach in psychiatric healthcare: co-designing a digital platform SG Sigurðardóttir, M Óskarsdóttir, O Ingimarsson, AS Islind Journal of Workplace Learning, 2023 | | 2023 |
| Náms-og atvinnuþátttaka ungs fólks á Íslandi eftir snemmíhlutun í geðrof RK Gudbrandsdottir, O Ingimarsson | | 2022 |
| Should Patients' Values Be Discussed in Relation to Long-Term Blood Monitoring Before and During Clozapine Treatment? O Ingimarsson, JH MacCabe, M Haraldsson, H Jónsdóttir, N Briem, ... Journal of Clinical Psychopharmacology 40 (4), 409-410, 2020 | | 2020 |
| HLA-DQB1 6672G> C INFLUENCES THE RISK OF CLOZAPINE-INDUCED AGRANULOCYTOSIS IN INDIVIDUALS OF EUROPEAN ANCESTRY B Konte, J Walters, I Giegling, S Legge, D Cohen, M Pirmohamed, ... European Neuropsychopharmacology 29, S866, 2019 | | 2019 |
